Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

Problems in the differential diagnosis of endometrial hyperplasia and carcinoma.

Silverberg SG.

Mod Pathol. 2000 Mar;13(3):309-27. Review.

3.

CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium.

Ohishi Y, Kaku T, Kobayashi H, Aishima S, Umekita Y, Wake N, Tsuneyoshi M.

Hum Pathol. 2008 Oct;39(10):1446-53. doi: 10.1016/j.humpath.2008.02.006. Epub 2008 Jul 11.

PMID:
18619643
4.

[Expression of glucose transporter-1 in endometrial hyperplasia and well-differentiated endometrioid adenocarcinoma].

Liu AJ, Hou N, Chen LZ.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2001 Aug;23(4):398-400. Chinese.

PMID:
12940086
5.

Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.

Ip PP, Irving JA, McCluggage WG, Clement PB, Young RH.

Am J Surg Pathol. 2013 Feb;37(2):167-77. doi: 10.1097/PAS.0b013e318272d428.

PMID:
23211295
6.

Prognostic aspects on endometrial hyperplasia and neoplasia.

Sivridis E, Giatromanolaki A.

Virchows Arch. 2001 Aug;439(2):118-26. Review.

PMID:
11561751
9.
10.

Autophagy in endometrial carcinomas and prognostic relevance of 'stone-like' structures (SLS): what is destined for the atypical endometrial hyperplasia?

Sivridis E, Giatromanolaki A, Liberis V, Koukourakis MI.

Autophagy. 2011 Jan;7(1):74-82. Epub 2011 Jan 1.

PMID:
21099253
11.

Hyperplasia and carcinoma in secretory endometrium: a diagnostic challenge.

Truskinovsky AM, Lifschitz-Mercer B, Czernobilsky B.

Int J Gynecol Pathol. 2014 Mar;33(2):107-13. doi: 10.1097/PGP.0b013e3182a2945d.

PMID:
24487463
12.

Hysteroscopy to detect Stage IA well-differentiated endometrioid adenocarcinoma of the endometrium.

Iha T, Shen H, Kanazawa K.

Acta Obstet Gynecol Scand. 2003 Apr;82(4):378-84.

PMID:
12716324
13.

[Histologic diagnosis of endometrial cancer].

Kaku T, Kawano Y, Hagiwara T.

Nihon Rinsho. 2004 Oct;62 Suppl 10:309-12. Review. Japanese. No abstract available.

PMID:
15535257
14.

New aspects of endometrial carcinoma.

Silverberg SG.

Clin Obstet Gynaecol. 1984 Apr;11(1):189-208. Review.

PMID:
6370532
15.

Low-grade endometrial adenocarcinoma: a diagnostic algorithm for distinguishing atypical endometrial hyperplasia and other benign (and malignant) mimics.

McKenney JK, Longacre TA.

Adv Anat Pathol. 2009 Jan;16(1):1-22. doi: 10.1097/PAP.0b013e3181919e15. Review.

PMID:
19098463
16.

Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma.

Kendall BS, Ronnett BM, Isacson C, Cho KR, Hedrick L, Diener-West M, Kurman RJ.

Am J Surg Pathol. 1998 Aug;22(8):1012-9.

PMID:
9706982
17.

Reproducibility of grading systems for endometrial endometrioid carcinoma and their relation with pathologic prognostic parameters.

Kapucuoglu N, Bulbul D, Tulunay G, Temel MA.

Int J Gynecol Cancer. 2008 Jul-Aug;18(4):790-6. Epub 2007 Sep 24.

PMID:
17892460
18.

Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.

Wheeler DT, Bristow RE, Kurman RJ.

Am J Surg Pathol. 2007 Jul;31(7):988-98.

PMID:
17592264
19.

Supplemental Content

Support Center